Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
4.720
+0.120 (2.61%)
At close: Dec 20, 2024, 4:00 PM
4.700
-0.020 (-0.42%)
After-hours: Dec 20, 2024, 7:31 PM EST

Precision BioSciences Revenue

Precision BioSciences had revenue of $576.00K in the quarter ending September 30, 2024, a decrease of -95.61%. This brings the company's revenue in the last twelve months to $75.10M, up 43.62% year-over-year. In the year 2023, Precision BioSciences had annual revenue of $48.73M with 94.15% growth.

Revenue (ttm)
$75.10M
Revenue Growth
+43.62%
P/S Ratio
0.37
Revenue / Employee
$688,954
Employees
109
Market Cap
36.21M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202348.73M23.63M94.15%
Dec 31, 202225.10M-90.43M-78.28%
Dec 31, 2021115.53M91.24M375.72%
Dec 31, 202024.29M2.05M9.20%
Dec 31, 201922.24M11.36M104.34%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Spectral AI 27.26M
Surrozen 10.00M
NEXGEL 6.73M
OncoCyte 709.00K
VYNE Therapeutics 493.00K
Revenue Rankings